{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:59:55Z","timestamp":1790985595393,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neuropharm.2011.06.017","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T11:32:45Z","timestamp":1309779165000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["The role of 5-HT1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: A possible antidepressant mechanism"],"prefix":"10.1016","volume":"62","author":[{"given":"Aparecida","family":"Vines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Marcia","family":"Delattre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo M.S.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00eds Soares","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Suchecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo B.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Tufik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia I.R.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvio M.","family":"Zanata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anete Curte","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.06.017_bib1","first-page":"35","article-title":"Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy","volume":"4","author":"Albert","year":"2010","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0006-3223(03)00073-8","article-title":"Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain","volume":"54","author":"Altar","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2008.03.023","article-title":"Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments","volume":"1211","author":"Balu","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biopsych.2005.05.009","article-title":"Nutrition and depression: implications for improving mental health among childbearing-aged women","volume":"58","author":"Bodnar","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.plefa.2008.03.005","article-title":"The role of polyunsaturated fatty acids (PUFAs) in development, aging and substance abuse disorders: review and propositions","volume":"78","author":"Borsonelo","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biopha.2006.09.015","article-title":"Dietary omega-3 fatty acids for women","volume":"61","author":"Bourre","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib7","series-title":"Experiments in Personality","first-page":"52","article-title":"Experiments in psychogenetics","author":"Broadhurst","year":"1960"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-2999(91)90433-Q","article-title":"Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test","volume":"196","author":"Cervo","year":"1991","journal-title":"Eur. J.\u00a0Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib9","first-page":"170","article-title":"The 5-HT1B receptor: behavioral implications","volume":"35","author":"Clark","year":"2001","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.nut.2008.12.008","article-title":"Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women","volume":"25","author":"Colangelo","year":"2009","journal-title":"Nutrition"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/sj.npp.1301287","article-title":"Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies","volume":"32","author":"Cremers","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01628-4","article-title":"Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test","volume":"436","author":"Cryan","year":"2002","journal-title":"Eur. J.\u00a0Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"Da Silva","year":"2008","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0701197","article-title":"(+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B\/1D receptors","volume":"121","author":"Davidson","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-2275(20)37235-7","article-title":"Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet","volume":"38","author":"Delion","year":"1997","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.plefa.2007.01.003","article-title":"Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies","volume":"76","author":"Eilander","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneumeth.2009.12.017","article-title":"Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions","volume":"187","author":"Elfving","year":"2010","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(02)03300-0","article-title":"Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion","volume":"954","author":"Farkas","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbr.2010.12.028","article-title":"Chronic omega-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol","volume":"219","author":"Ferraz","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.plefa.2008.02.001","article-title":"The antidepressant role of dietary long-chain polyunsaturated n-3 fatty acids in two phases in the developing brain","volume":"78","author":"Ferraz","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0014-2999(76)90145-X","article-title":"Effect of antipsychotic drugs on the firing of dorsal raphe cells. II. Reversal by picrotoxin","volume":"39","author":"Gallager","year":"1976","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1471-4159.2003.01827.x","article-title":"Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice","volume":"86","author":"Gardier","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0028-3908(97)00052-X","article-title":"Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment","volume":"36","author":"Gundlah","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2011.03.004","article-title":"5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test","author":"Gunther","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-2999(00)00723-8","article-title":"Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine","volume":"407","author":"Hajos-Korcsok","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0028-3908(03)00030-3","article-title":"Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors","volume":"44","author":"Harkin","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.bjp.0703297","article-title":"Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat","volume":"130","author":"Hervas","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","article-title":"International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000017478","article-title":"The role of dietary n-6 and n-3 fatty acids in the developing brain","volume":"22","author":"Innis","year":"2000","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2004.07.065","article-title":"The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels","volume":"1024","author":"Jacobsen","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib33","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1471-4159.2004.02953.x","article-title":"Differences in serotonergic neurotransmission between rats displaying high or low anxiety\/depression-like behaviour: effects of chronic paroxetine treatment","volume":"92","author":"Keck","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuroscience.2010.05.054","article-title":"Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice","volume":"169","author":"Klein","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0022-3565(25)10650-2","article-title":"Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in\u00a0vivo","volume":"274","author":"Kreiss","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib36","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.psyneuen.2008.06.012","article-title":"Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: interactions with reproductive status in female rats","volume":"33","author":"Levant","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.05.016","article-title":"Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats","volume":"1101","author":"Lima","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.psyneuen.2008.06.007","article-title":"Chronic stress during paradoxical sleep deprivation increases paradoxical sleep rebound: association with prolactin plasma levels and brain serotonin content","volume":"33","author":"Machado","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between BDNF and serotonin: role in mood disorders","volume":"33","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jpsychires.2008.09.011","article-title":"Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects","volume":"43","author":"Mcnamara","year":"2009","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.plefa.2006.07.010","article-title":"Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology","volume":"75","author":"Mcnamara","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10284150410001704525","article-title":"Effects of fish oil on the central nervous system: a new potential antidepressant?","volume":"7","author":"Naliwaiko","year":"2004","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051156","article-title":"Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test","volume":"147","author":"Page","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(85)90857-1","article-title":"Quantitative autoradiographic mapping of\u00a0serotonin receptors in the rat brain. II. Serotonin-2 receptors","volume":"346","author":"Pazos","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2009.11.037","article-title":"A\u00a0longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain","volume":"628","author":"Popa","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jad.2009.08.004","article-title":"Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome","volume":"123","author":"Riemer","year":"2009","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib50","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1046\/j.1471-4159.1997.68062593.x","article-title":"Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors","volume":"68","author":"Romero","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.mehy.2006.07.054","article-title":"Omega-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism","volume":"68","author":"Ross","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib52","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2174\/138945009789735192","article-title":"The 5-HT1B receptor: a novel target for the pathophysiology of depression","volume":"10","author":"Ruf","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib53","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT(1A) receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchemneu.2004.03.010","article-title":"Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei","volume":"29","author":"Serrats","year":"2005","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tips.2007.10.009","article-title":"Important messages in the \u2018post\u2019: recent discoveries in 5-HT neurone feedback control","volume":"28","author":"Sharp","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1117571","article-title":"Alterations in 5-HT1B receptor function by p11 in depression-like states","volume":"311","author":"Svenningsson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pbb.2010.02.006","article-title":"Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test","volume":"95","author":"Ulak","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.psyneuen.2008.08.025","article-title":"PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus","volume":"34","author":"Venna","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib60","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0361-9230(92)90169-X","article-title":"GABAergic innervation of serotonergic neurons in the dorsal raphe nucleus of the rat studied by electron microscopy double immunostaining","volume":"29","author":"Wang","year":"1992","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2011.06.017_bib61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00213-002-1341-6","article-title":"Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat","volume":"166","author":"Wegener","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF02244228","article-title":"Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test","volume":"101","author":"Wieland","year":"1990","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2010.184","article-title":"The role of BDNF in depression on the basis of its location in the neuronal circuitry","volume":"32","author":"Yu","year":"2011","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.neuropharm.2011.06.017_bib64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","article-title":"Evidence for serotonin subtypes involvement in agmatine antidepressant-like effect in the mouse forced swimming test","volume":"1023","author":"Zomkowski","year":"2004","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:40:30Z","timestamp":1758436830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811002619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0028390811002619"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.06.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of 5-HT1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: A possible antidepressant mechanism","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}